<DOC>
	<DOC>NCT01641185</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and feasibility of primary hypofractionated irradiation of the prostate with carbon ions or protons using the raster scan technique.</brief_summary>
	<brief_title>Ion Prostate Irradiation</brief_title>
	<detailed_description>as published: Habl G, Hatiboglu G, Edler L, Uhl M, Krause S, Roethke M, Schlemmer HP, Hadaschik B, Debus J, Herfarth K: Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique. BMC cancer 2014, 14(1):202. http://www.ncbi.nlm.nih.gov/pubmed/24641841</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>histological proven carcinoma of the prostate with Gleason score risk of lymphe node involvement of &lt;15% calculated by the Yaleformula; Risk [%] = [GS 5] x [PSA/3 + 1.5 x T], mit T = 0, 1, and 2 for cT1c, cT2a, und cT2b/cT2c KarnofskyIndex â‰¥ 70% age between 40 and 80 years PSA Stadium IV (distant metastases) Lymphogenous Metastases hip replacement former irradiation of the pelvis pacemaker defibrillator</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>prostate</keyword>
	<keyword>IPI</keyword>
	<keyword>hypofractionation</keyword>
	<keyword>carbon ions</keyword>
	<keyword>proton</keyword>
</DOC>